News | Intra-Vascular Ultrasound (IVUS) | February 29, 2016

Study Finds Intravascular Ultrasound Beneficial in Diagnosing Vein Obstructions

IVUS finds 88 percent more lesions than gold-standard multiplanar X-ray venography

Philips, Volcano, IVUS, vein obstruction diagnosis, multiplanar X-ray venography, VIDIO study

February 29, 2016 — Philips announced that new clinical trial data demonstrates the benefits of its intravascular ultrasound (IVUS) technology in the diagnosis of iliofemoral venous obstruction i.e. narrowed or blocked leg veins. The study, which compared IVUS to conventional contrast-enhanced X-ray imaging of the veins (also known as multiplanar X-ray venography), was presented by Paul J. Gagne, M.D., chief of vascular surgery at Norwalk Hospital in Norwalk, Conn.

In image-guided treatments of the blood vessels, there is an increasing trend to use IVUS catheters that are capable of producing ultrasound images of the interior of blood vessels. There is a growing body of clinical evidence that the use of this technology in conjunction with interventional X-ray helps improve procedural outcomes.

In the 100-patient prospective multicenter Venogram Versus Intravascular Ultrasound for Diagnosing Iliofemoral Vein Obstruction (VIDIO) study, 29 percent of patients were assessed to be free of lesions based on their X-ray venogram results, but had lesions detected by Philips Volcano’s phased-array IVUS technology. The results of the study, in which IVUS in total detected 88 percent more lesions than multiplanar X-ray venography (as assessed by investigators at the point-of-care), were announced at the American Venous Forum 28th annual meeting.

Iliac/common femoral vein obstruction (ICFVO) is a significant cause of chronic venous insufficiency (CVI) — a condition that is estimated to affect between 10-35 percent of adults in the United States, resulting in approximately 4.6 million lost workdays. Iliofemoral vein obstruction, which can eventually lead to swelling, chronic pain and ulceration, can be treated via angioplasty and stenting with profound benefits to the patient’s quality of life. However, many patients exhibiting symptoms may not be diagnosed with venography. There is, therefore, a real need for better ways to diagnose the condition.

“These results of the VIDIO study clearly show that IVUS is better at detecting lesions than multiplanar X-ray venography, the prior imaging gold standard,” said Gagne, global principal investigator of the study. “IVUS is now my preferred imaging modality of choice for identifying this treatable condition, and the VIDIO study shows how well these patients can do with the appropriate treatment.”

The study was designed to prospectively compare the diagnostic performance of conventional multiplanar venography versus IVUS for diagnosing and treating ICFVO; and to characterize patient response to iliofemoral vein intervention in terms of clinical improvement and quality of life over six months of follow-up.

Between July 2014 and July 2015, the study enrolled 100 patients with advanced venous insufficiency (CEAP* score 4, 5 and 6) at 11 U.S. and three European centers. Each patient had a multiplanar venogram performed, with an initial lesion characterization and treatment strategy recorded by the interventionalist based on the venogram. An assessment with Philips Volcano phased-array IVUS was then performed, with a second lesion characterization and treatment strategy recorded by the interventionalist. Stenting treatment was subsequently performed at the discretion of the interventionalist. All patients were followed for six months after the index procedure.

Across the full 100 patients enrolled, according to investigator readings at the time of the index procedure, IVUS detected 88 percent more lesions than multiplanar venography (124 vs 66) (P < .0001). In addition, 29 percent of patients were ruled negative by venograms, while showing positive findings from IVUS (19 vs 48).

For more information: www.volcanocorp.com

Related Content

Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | May 07, 2018 | Simon Trinh and Jeffrey Wong
The European interventional cardiology market is currently valued at nearly $1.4 billion.
Videos | Cath Lab | May 07, 2018
Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs have
360 Photos | Cath Lab | April 20, 2018
A 360 degree view of the newest cath lab at Northwestern Medicine Central DuPage Hospital in Winfield, Ill., located
SCAI Announces Global Lecture Series for 2018 Scientific Sessions
News | Cath Lab | April 18, 2018
Many of the world’s leading interventional cardiologists and cardiovascular professionals will convene in San Diego,...
Overlay Init